Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
Meijer D, van Leeuwen PJ, Eppinga WSC, Vanneste BGL, Meijnen P, Daniels LA, van den Bergh RCN, Lont AP, Bodar YJL, Ettema RH, de Bie KCC, Oudshoorn FHK, Nieuwenhuijzen JA, van der Poel HG, Donswijk ML, Heymans MW, Oprea-Lager DE, Schaake EE, Vis AN. Meijer D, et al. Among authors: vis an. Eur Urol Open Sci. 2024 Feb 6;61:37-43. doi: 10.1016/j.euros.2024.01.009. eCollection 2024 Mar. Eur Urol Open Sci. 2024. PMID: 38384437 Free PMC article.
Prostate cancer detection at low prostate specific antigen.
Schröder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Schröder FH, et al. Among authors: vis an. J Urol. 2000 Mar;163(3):806-12. J Urol. 2000. PMID: 10687982 Clinical Trial.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer.
Muller BG, Swaan A, de Bruin DM, van den Bos W, Schreurs AW, Faber DJ, Zwartkruis EC, Rozendaal L, Vis AN, Nieuwenhuijzen JA, van Moorselaar RJ, van Leeuwen TG, de la Rosette JJ. Muller BG, et al. Among authors: vis an. Technol Cancer Res Treat. 2017 Feb;16(1):57-65. doi: 10.1177/1533034615626614. Epub 2016 Jul 7. Technol Cancer Res Treat. 2017. PMID: 26818025 Free PMC article.
Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
Bosschieter J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, Witte B, Newling D, Beckers GMA, van Moorselaar RJA. Bosschieter J, et al. Among authors: vis an. Eur Urol. 2018 Feb;73(2):226-232. doi: 10.1016/j.eururo.2017.06.038. Epub 2017 Jul 10. Eur Urol. 2018. PMID: 28705539 Clinical Trial.
Effectiveness, cost-utility and implementation of a decision aid for patients with localised prostate cancer and their partners: study protocol of a stepped-wedge cluster randomised controlled trial.
Al-Itejawi HHM, van Uden-Kraan CF, van de Ven PM, Coupé VMH, Vis AN, Nieuwenhuijzen JA, van Moorselaar JA, Verdonck-de Leeuw IM. Al-Itejawi HHM, et al. Among authors: vis an. BMJ Open. 2017 Sep 15;7(9):e015154. doi: 10.1136/bmjopen-2016-015154. BMJ Open. 2017. PMID: 28918408 Free PMC article. Clinical Trial.
161 results